Old Web
English
Sign In
Acemap
>
Paper
>
1015P A phase I dose-escalation study of HBM4003: An anti-CTLA-4 heavy-chain-only mAb
1015P A phase I dose-escalation study of HBM4003: An anti-CTLA-4 heavy-chain-only mAb
2021
P de Souza
John E.S. Park
D. Day
S. Frentzas
A.M. Haydon
J. Ji
M.M. de Assis
X Chen
X Gan
X. Tao
R. Zuo
G Ross
L. Lu
Keywords:
anti ctla 4
Pharmacology
dose escalation
Phase (matter)
Monoclonal antibody
Medicine
Heavy chain
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]